Protein profile

PA5131

2,3-bisphosphoglycerate-independent phosphoglycerate mutase

Genome: NC_002516.2

Gene: pgm gpmI PA5131 Structure source: AlphaFold UniProt Q9HU53
Amino acids 515
Annotations 10
Features 23
PDB binders 3
Druggability 0.405

Overview

Basic information about this protein and its source genome.

Accession
PA5131
Gene
pgm gpmI PA5131
Status
annotated
Amino acids
515
Structure source
AlphaFold

Target profile

Computed evidence for target prioritization.

Human off-target
No hit
Gut microbiome off-target
hit
Essential (DEG)
Y
Localization
Cytoplasmic

Selected Druggability evidence

Selected Druggability is the FPocket score chosen for ranking using the curated structure priority. The 3D viewer may show a different loaded structure, so its visible pockets can differ.

FPocket 0.405
Structure
Pocket

Sequence

Primary amino-acid sequence viewer.

Functional Annotations

Enzyme classification and Gene Ontology terms linked to this protein.

1 EC 9 GO

Enzyme Commission (EC)

1

Gene Ontology (GO)

9
  • GO:0005829 The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
  • GO:0030145 Binding to a manganese ion (Mn).
  • GO:0004619 Catalysis of the reaction: (2R)-2-phosphoglycerate = (2R)-3-phosphoglycerate.
  • GO:0005975 The chemical reactions and pathways involving carbohydrates, any of a group of organic compounds based of the general formula Cx(H2O)y.
  • GO:0006007 The chemical reactions and pathways resulting in the breakdown of glucose, the aldohexose gluco-hexose.
  • GO:0006096 The chemical reactions and pathways resulting in the breakdown of a carbohydrate into pyruvate, with the concomitant production of a small amount of ATP and the reduction of NAD(P) to NAD(P)H. Glycolysis begins with the metabolism of a carbohydrate to generate products that can enter the pathway and ends with the production of pyruvate. Pyruvate may be converted to acetyl-coenzyme A, ethanol, lactate, or other small molecules.
  • GO:0005737 The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
  • GO:0003824 Catalysis of a biochemical reaction at physiological temperatures. In biologically catalyzed reactions, the reactants are known as substrates, and the catalysts are naturally occurring macromolecular substances known as enzymes. Enzymes possess specific binding sites for substrates, and are usually composed wholly or largely of protein, but RNA that has catalytic activity (ribozyme) is often also regarded as enzymatic.
  • GO:0046872 Binding to a metal ion.

Sequence Features

Domain/signature hits from InterPro and related databases.

23 records
Show feature table
Start End DB Term Name
6 512 NCBIfam TIGR01307 2,3-bisphosphoglycerate-independent phosphoglycerate mutase
6 512 InterPro IPR005995 Phosphoglycerate mutase, 2,3-bisphosphoglycerate-independent
79 311 SUPERFAMILY SSF64158 2,3-Bisphosphoglycerate-independent phosphoglycerate mutase, substrate-binding domain
79 311 InterPro IPR036646 BPG-independent phosphoglycerate mutase, domain B superfamily
79 313 FunFam G3DSA:3.40.1450.10:FF:000001 2,3-bisphosphoglycerate-independent phosphoglycerate mutase
5 512 PANTHER PTHR31637 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT PHOSPHOGLYCERATE MUTASE
5 512 InterPro IPR005995 Phosphoglycerate mutase, 2,3-bisphosphoglycerate-independent
5 512 SUPERFAMILY SSF53649 Alkaline phosphatase-like
5 512 InterPro IPR017850 Alkaline-phosphatase-like, core domain superfamily
79 313 Gene3D G3DSA:3.40.1450.10 -
79 313 InterPro IPR036646 BPG-independent phosphoglycerate mutase, domain B superfamily
84 300 Pfam PF06415 BPG-independent PGAM N-terminus (iPGM_N)
84 300 InterPro IPR011258 BPG-independent PGAM, N-terminal
6 512 CDD cd16010 iPGM
1 514 PIRSF PIRSF001492 IPGAM
1 514 InterPro IPR005995 Phosphoglycerate mutase, 2,3-bisphosphoglycerate-independent
7 510 Gene3D G3DSA:3.40.720.10 Alkaline Phosphatase, subunit A
7 510 InterPro IPR017850 Alkaline-phosphatase-like, core domain superfamily
6 513 Hamap MF_01038 2,3-bisphosphoglycerate-independent phosphoglycerate mutase [gpmI].
6 513 InterPro IPR005995 Phosphoglycerate mutase, 2,3-bisphosphoglycerate-independent
6 501 Pfam PF01676 Metalloenzyme superfamily
6 501 InterPro IPR006124 Metalloenzyme
312 510 FunFam G3DSA:3.40.720.10:FF:000001 2,3-bisphosphoglycerate-independent phosphoglycerate mutase

3D Structure

Selected loaded structure. Experimental PDB entries may cover only a portion of the sequence; predicted models typically cover the full protein.

3D visualization script Full viewer

Loading 3D structure...

Legend High Medium Low

Structural evidence

0 + 1

Experimental PDB entries and predicted models. Click Switch to display a different structure in the viewer.

Entry Method Resolution Chain Coverage Links Status
AlphaFold PA5131
AlphaFold full sequence Viewing
Pocket details FPocket · P2Rank — toggle visibility and zoom from here, or open full viewer

Pockets (FPOCKET)

Showing top-ranked FPocket candidates by druggability. Druggability is color-coded: high (0.7 or higher), medium (0.4 to 0.69), low (below 0.4).

FPOCKET Sticks Spheres Surfaces Druggability Labels Zoom Positions
1 0.318
12 0.271
2 0.249

Ligand evidence

Ligands grouped by evidence source. PDB ligands keep the source crystal visible, and loaded crystals can be opened directly in the structure viewer.

40 records

Structural evidence inferred from similar proteins. The source crystal indicates where the ligand was observed; the UniProt column identifies the homologous protein carrying that ligand.

Show only:
Ligand Source crystal UniProt (homolog) MW · LogP · TPSA Lipinski PAINS SMILES
2PG Q2G029 186.1 Da LogP -1.46 TPSA 124.3 ✓ Ro5 ✓ Clean C([C@H](C(=O)O)OP(=O)(O)O)O
3PG A0A059ZPG7 186.1 Da LogP -1.46 TPSA 124.3 ✓ Ro5 ✓ Clean C([C@H](C(=O)O)O)OP(=O)(O)O
DTT Q2G029 154.3 Da LogP -0.43 TPSA 40.5 ✓ Ro5 ✓ Clean C([C@@H]([C@H](CS)O)O)S

PDB and ChEMBL records on this protein are shown in full. ChEMBL records from similar proteins are capped at the top 100 per protein (by pchembl) and ZINC at the top 50 (Tanimoto ≥ 0.5). ADME columns are descriptor-based screening flags, not experimental toxicity results.